Michael Chambers was elected to our Board in June 2022.
Mr. Chambers co-founded Aldevron, based in Fargo, N.D., in 1998, and served as its chief executive officer for more than 20 years before serving as Executive Chairman of the Board until 2021 when Aldevron was acquired by Danaher Corporation. As founder, Mr. Chambers oversaw the growth of Aldevron into a world-class service organization, specializing in nucleic acid and protein production, antibody development, and custom services with operations in the United States and Europe. He currently serves on the Board of Directors at Calviri, Inc.
In 2018, Mr. Chambers was named one of the “100 Most Intriguing Entrepreneurs” by Goldman Sachs. He earned his bachelor’s degree in biotechnology, microbiology, and chemistry from North Dakota State University.